An October 2026 policy allows the FDA to expand access to six peptides, including BPC-157.

Unregulated peptides for weight loss, muscle building, longevity and more are a roaring wellness fad – even though these substances have not been proved safe and effective and have not been approved by the U.S. Food and Drug Administration.

Until now, consumers were getting wellness peptides online through the so-called gray market, where companies rely on legal loopholes to sell them. Due to a push from Health and Human Services Secretary Robert F. Kennedy Jr., a vocal proponent of using peptides, an HHS policy on Oct. 29, 2026, will expand access to six peptides by allowing specialized pharmacies to make and sell them.

Originally published on theconversation.com, part of the BLOX Digital Content Exchange.